Published in Br J Cancer on May 01, 1998
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science (1985) 6.56
Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta (1990) 5.55
Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science (1993) 5.50
Higher level organization of individual gene transcription and RNA splicing. Science (1993) 4.50
Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J (1987) 4.33
Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res (1993) 2.72
Does antisense exist? Nat Med (1995) 2.01
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Commun (1993) 1.91
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc Natl Acad Sci U S A (1991) 1.78
Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol Cell Biol (1995) 1.63
Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med (1994) 1.59
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene (1994) 1.51
Antisense has growing pains. Science (1995) 1.49
A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci U S A (1996) 1.38
c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res (1994) 1.33
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1994) 1.25
Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res (1992) 1.24
erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification. Br J Cancer (1994) 1.07
Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Biochem Biophys Res Commun (1994) 0.87
Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proc Natl Acad Sci U S A (1994) 0.85
Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay. Proc Natl Acad Sci U S A (1995) 0.82
Scintigraphic imaging of oncogenes with antisense probes: does it make sense? Eur J Nucl Med (1995) 0.81
Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. Cancer Gene Ther (1994) 0.80
Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV). Biochim Biophys Acta (1997) 0.79
Synthesis and characterization of supramolecular biovector (SMBV) specifically designed for the entrapment of ionic molecules. Biochim Biophys Acta (1995) 0.79
Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors. Vaccine (1994) 0.77
Preclinical testing of an anti-erbB-2 recombinant toxin. Breast Cancer Res Treat (1996) 0.77
c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells. Int J Cancer (1995) 0.77
Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa. Lancet (1991) 5.11
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 1.97
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
The influence of food on the pharmacokinetics of CGP 6140 (amocarzine) after oral administration of a 1200 mg single dose to patients with onchocerciasis. Br J Clin Pharmacol (1990) 1.76
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. Bone Marrow Transplant (2002) 1.46
Fast kinetics studies of Escherichia coli electrotransformation. Eur J Biochem (1992) 1.28
Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J Biol Chem (2000) 1.27
HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ (2011) 1.23
Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem (1998) 1.11
GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res (1997) 1.11
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem (2000) 1.10
Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers. Pharm Res (2000) 1.09
Improving knowledge navigation with adaptive hypermedia. Med Inform Internet Med (2000) 1.07
DI2ADEM: an adaptive hypermedia designed to improve access to relevant medical information. Proc AMIA Symp (2000) 1.07
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody. Proc Natl Acad Sci U S A (2000) 1.07
Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. Clin Microbiol Infect (2009) 1.06
Mycobacteria glycolipids as potential pathogenicity effectors: alteration of model and natural membranes. Biochemistry (1990) 1.05
In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther (2008) 1.02
Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther (1998) 0.99
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int J Cancer (1993) 0.97
[Utilization of mosquitoes impregnated with deltamethrin in the battle against malaria]. Parassitologia (1984) 0.97
Biodistribution study of 99mTc-labeled LDL in B16-melanoma-bearing mice. Visualization of a preferential uptake by the tumor. Int J Cancer (1993) 0.97
Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068. Int J Cancer (1999) 0.96
Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization. Bioconjug Chem (1996) 0.93
Geranylgeranyl transferase inhibition stimulates anti-melanoma immune response through MHC Class I and costimulatory molecule expression. FASEB J (2005) 0.92
[Risk factors for human African trypanosomiasis in the Bipindi region of Cameroon]. Med Trop (Mars) (2001) 0.92
[Imported malaria at the Marseilles Hôpital-Nord, France: a prospective study on 352 cases between 2001 and 2003]. Med Mal Infect (2005) 0.90
An integrated approach to distance learning with digital video in the French-speaking Virtual Medical University. Int J Med Inform (2007) 0.90
Tumor incidence in related hematopoietic stem cell donors. Bone Marrow Transplant (2010) 0.89
Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells. Cancer Res (1992) 0.88
[Risk factors in prematurity and intrauterine growth retardation in Burkina Faso]. Rev Epidemiol Sante Publique (1995) 0.88
Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells. Cancer Res (1997) 0.87
Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells. Biochem Biophys Res Commun (1999) 0.87
Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infections in Burkina Faso. Int J STD AIDS (1995) 0.87
Etiologic study of genitourinary infections in women of childbearing age in Bobo-Dioulasso, Burkina Faso, 1992. Sex Transm Dis (1997) 0.87
Serum protein signature may improve detection of ductal carcinoma in situ of the breast. Oncogene (2009) 0.87
Review on Medusa:a polymer-based sustained release technology for protein and peptide drugs. Expert Opin Drug Deliv (2007) 0.87
Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem Biophys Res Commun (1996) 0.86
Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie (1993) 0.86
[The focus of human trypanosomiasis in Campo (Cameroon). History and endemic situation in 1998]. Bull Soc Pathol Exot (1999) 0.86
Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Bone Marrow Transplant (2008) 0.85
Low density lipoprotein for cytotoxic drug targeting: improved activity of elliptinium derivative against B16 melanoma in mice. Br J Cancer (1993) 0.85
The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Cancer Gene Ther (2000) 0.84
Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication. Cell Death Differ (2005) 0.84
Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of two studies in a hyperendemic region in West Africa. Lancet (1988) 0.84
The French Virtual Medical University. Stud Health Technol Inform (2000) 0.83
Epstein-Barr virus-associated hepatic leiomyosarcoma after renal transplantation: case report. Transplant Proc (2010) 0.83
Proliferative effect of high density lipoprotein (HDL) and HDL fractions (HDL1,2, HDL3) on virus transformed lymphoblastoid cells. Biochim Biophys Acta (1989) 0.82
[Diagnosis and treatment of the encrusted cystitis]. Actas Urol Esp (2010) 0.82
A new family of potential oncostatics: 2-chloroethylnitrososulfamides (CENS)--I. Synthesis, structure, and pharmacological evaluation (preliminary results). Bioorg Med Chem (1996) 0.81
An in vitro study of hemicholinium-3 on phospholipid metabolism of Krebs II ascites cells. Biochem Pharmacol (1983) 0.81
Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro. Biochem Pharmacol (1990) 0.81
Phospholipid exchange proteins from platelet cytosol possibly involved in phospholipid effect. Biochem Biophys Res Commun (1981) 0.80
Synthesis and application of a N-1' fluorescent biotinyl derivative inducing the specific carboxy-terminal dual labeling of a novel RhoB-selective scFv. Bioconjug Chem (2009) 0.80
[Impact of curtains and blankets impregnated with permethrin on the malarial indicators and the number of malarial attacks per child in a village in an area hyperendemic for malaria on the Malian savannah (preliminary results of the first year study)]. Bull Soc Pathol Exot (1991) 0.80
Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis. J Clin Chem Clin Biochem (1986) 0.80
Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography. Cancer Chemother Pharmacol (1986) 0.80
[Preparedness for influenza A/H5N1 pandemic in Niger: a study on health care workers' knowledge and global organization of health activities]. Bull Soc Pathol Exot (2011) 0.79
Synthesis and characterization of supramolecular biovector (SMBV) specifically designed for the entrapment of ionic molecules. Biochim Biophys Acta (1995) 0.79
Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV). Biochim Biophys Acta (1997) 0.79
Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation. Bone Marrow Transplant (1999) 0.79
The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS. Radiat Res (1999) 0.78
Intrahepatic polyamine levels during rat liver carcinogenesis induced by N-2-fluorenylacetamide. Carcinogenesis (1981) 0.78
Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants. Bone Marrow Transplant (2000) 0.78
[Development of farsenyl transferase inhibitors as anticancer agents]. Ann Pharm Fr (2005) 0.78
Enhancement of anti-tumor immunity by injection of fibroblasts genetically engineered to produce IL-12 and to express CD70. Adv Exp Med Biol (1998) 0.78
Hyperphosphatasemia related to three intestinal alkaline phosphatase isoforms: biochemical study. Clin Chim Acta (1990) 0.78
Electropermeabilization mediates a stable insertion of glycophorin A with Chinese hamster ovary cell membranes. Eur J Biochem (1994) 0.78
Uptake and binding of teniposide (VM26) in Krebs II ascites cells. Biochem Pharmacol (1987) 0.78
[Ivermectin and pregnancy in mass treatment in Mali]. Bull Soc Pathol Exot (1992) 0.78
Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol (2000) 0.78
[Cancer of the prostate: the markers other than prostatic acid phosphatase]. Bull Cancer (1985) 0.77
High density lipoprotein3 binding sites are related to DNA biosynthesis in the adenocarcinoma cell line A549. J Lipid Res (1993) 0.77
Reversion of transformed phenotype of human adenocarcinoma A549 cells by expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase complementary DNA. Cell Growth Differ (1995) 0.77
Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet (1991) 0.77
[Optimizing the response to epidemics of meningococcal meningitis: report of a workshop of experts at CERMES (Niamey, Niger, 12th to 14th January 1998)]. Sante (1998) 0.77
Involvement of tyrosine kinase activity in the low-density lipoprotein receptor expression in human lung adenocarcinoma cell line A549. Biochimie (1996) 0.77
Migration and death of skin-dwelling Onchocerca volvulus microfilariae after treatment with ivermectin. Trop Med Parasitol (1991) 0.77
Tender Nesting Polypore (Hapalopilus rutilans) poisoning: report of two cases. Clin Toxicol (Phila) (2013) 0.77
Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro. Eur J Cancer Clin Oncol (1989) 0.77
Repeated peripheral stem cell mobilization in healthy donors: time-dependent changes in mobilization efficiency. Br J Haematol (1999) 0.77
Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells. Biochem J (1998) 0.77
Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melanin. Int J Radiat Oncol Biol Phys (1989) 0.77
Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody. Br J Cancer (1996) 0.77
Autoradiographic distribution of [14C]-labelled pimonidazole in rhabdomyosarcoma-bearing rats and pigmented mice. Cancer Chemother Pharmacol (1988) 0.77
Erythrocytes as carriers of ricin A chain: effects on the erythrophagocytic cells. Adv Exp Med Biol (1992) 0.76